Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05732142 · ClinicalTrials.gov registry record · NA
Postpartum Integration of Vaccines and Contraception Trial
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 293
- Enrollment target
NCT05732142: Completed NA study, sponsored by University of California, San Diego.
NCT05732142 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 293 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05732142, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 293 participants
- Enrollment target
Study Summary
This study aims to examine how to implement a gender-transformative post-partum family planning program integrated into community-based infant vaccination services, and to evaluate preliminary effectiveness of this approach on postpartum contraceptive use in a low resource, rural setting.
Primary Outcome
Contraceptive use will be measured through a self-reported survey collected at 6 months postpartum.
Interventions
- OTHER Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming(PIVoT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT05732142 record still lists
NCT05732142 is an interventional study that assigns participants to a tested intervention. The registered 293 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming(PIVoT) is the first listed.
NCT05732142 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05732142 about?
NCT05732142 is a clinical study titled "Postpartum Integration of Vaccines and Contraception Trial". This study aims to examine how to implement a gender-transformative post-partum family planning program integrated into community-based infant vaccination services, and to evaluate preliminary effectiveness of this approach on postpartum contraceptive use in a low resource, rural setting.
What is the current status of trial NCT05732142?
This trial is currently completed. It is a NA study. The enrollment target is 293 participants. The study started on 2023-09-01. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT05732142?
The interventions under investigation include: Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming(PIVoT) (OTHER).
Who is sponsoring clinical trial NCT05732142?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05732142's enrollment target sits among peer trials
293 375th of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI